Treatment of cutaneous lymphoid hyperplasia with thalidomide: report of two cases.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10365937.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cutaneous benign lymphoid hyperplasia is a B-cell pseudolymphoma of unknown origin. The most favored sites of involvement include the face. We report two cases involving the nose that showed complete and stable regression after a 2-month treatment course with thalidomide.
Medical subject headings
- Dermatologic Agents
- Facial Dermatoses
- Pseudolymphoma
- Thalidomide